Holen Sie sich die Stockscreener-App
4.00
5.88%
-0.25
Handel nachbörslich:
4.29
0.29
+7.25%
Schlusskurs vom Vortag:
$4.25
Offen:
$4.26
24-Stunden-Volumen:
1.64M
Relative Volume:
2.29
Marktkapitalisierung:
$507.43M
Einnahmen:
$433.14M
Nettoeinkommen (Verlust:
$4.95M
KGV:
112.04
EPS:
0.0357
Netto-Cashflow:
$6.55M
1W Leistung:
-6.54%
1M Leistung:
-6.76%
6M Leistung:
-24.24%
1J Leistung:
+43.88%
1-Tages-Spanne:
$3.94
$4.30
1-Wochen-Bereich:
$3.94
$4.39
52-Wochen-Spanne:
$2.6101
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Firmenname
Organogenesis Holdings Inc
Sektor
Telefon
781-575-0775
Adresse
85 DAN ROAD, CANTON, MA
Vergleichen Sie ORGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.00 | 539.15M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Lake Street | Buy |
| 2024-02-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-11-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
| 2019-04-17 | Eingeleitet | Oppenheimer | Outperform |
| 2019-04-11 | Eingeleitet | SunTrust | Buy |
Alle ansehen
Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten
Organogenesis Applauds CMS’s Significant Step In Payment Reform - The Manila Times
Organogenesis Holdings Inc. Commends CMS on Payment Reform for Skin Substitutes and CTPs Under CY 2026 Fee Schedule - Quiver Quantitative
Organogenesis (Nasdaq: ORGO) applauds CMS 2026: per‑cm payments, FDA classifications finalized - Stock Titan
Is Organogenesis Holdings Inc. stock positioned for digital transformation2025 Trade Ideas & Verified Swing Trading Watchlist - newser.com
Will Organogenesis Holdings Inc. stock maintain momentum in 2025Trade Risk Summary & Weekly High Potential Stock Alerts - newser.com
Why Organogenesis Holdings Inc. stock could be next big winnerTrade Risk Report & Safe Entry Point Identification - newser.com
Asia Pacific Wound Care Biologics Market Growth in Future Scope - openPR.com
Should I hold or sell Organogenesis Holdings Inc. stock in 2025July 2025 Setups & High Accuracy Investment Signals - newser.com
Will Organogenesis Holdings Inc. outperform the marketJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Real time pattern detection on Organogenesis Holdings Inc. stockJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Detecting price anomalies in Organogenesis Holdings Inc. with AIJuly 2025 Institutional & Risk Controlled Daily Plans - newser.com
Is Organogenesis Holdings Inc. stock oversold or undervalued2025 Market Sentiment & Short-Term High Return Ideas - newser.com
Why pension funds invest in Organogenesis Holdings Inc. (2PQ) stock2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com
Using Python tools to backtest Organogenesis Holdings Inc. strategiesJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com
What indicators show strength in Organogenesis Holdings Inc.Quarterly Profit Report & Daily Entry Point Trade Alerts - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationWeekly Volume Report & Weekly Market Pulse Updates - newser.com
Has Organogenesis Holdings Inc. formed a bullish divergenceJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Why Organogenesis Holdings Inc. (2PQ) stock stays on top picksWeekly Profit Analysis & Reliable Entry Point Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organogenesis Holdings Inc. (ORGO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Why Organogenesis Holdings Inc. stock is trending among retail tradersBond Market & Long-Term Growth Plans - newser.com
Can Organogenesis Holdings Inc. rally from current levelsWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Organogenesis (NASDAQ: ORGO) awards CTO inducement equity at $4.17, 4-year vesting - Stock Titan
Organogenesis Holdings Inc. (ORGO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Top chart patterns to watch in Organogenesis Holdings Inc.July 2025 Update & High Yield Stock Recommendations - newser.com
Published on: 2025-10-31 05:50:02 - newser.com
What to expect from Organogenesis Holdings Inc. in the next 30 daysWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-10-31 03:32:15 - newser.com
What high frequency data says about Organogenesis Holdings Inc.July 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Organogenesis Holdings Inc. (ORGO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Organogenesis (ORGO) Projected to Post Earnings on Thursday - MarketBeat
Key resistance and support levels for Organogenesis Holdings Inc.July 2025 Action & Stepwise Trade Signal Implementation - newser.com
Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):